These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28256759)

  • 1. Cutaneous side-effects of biologics in immune-mediated disorders: A histopathological perspective.
    Succaria F; Bhawan J
    J Dermatol; 2017 Mar; 44(3):243-250. PubMed ID: 28256759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety issues of biologics in pregnant patients with rheumatic diseases.
    Ostensen M
    Ann N Y Acad Sci; 2014 May; 1317():32-8. PubMed ID: 24840548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
    Siddiqui MA
    Curr Opin Rheumatol; 2007 May; 19(3):308-13. PubMed ID: 17414961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapies for rheumatoid arthritis: progress to date.
    Malviya G; Salemi S; Laganà B; Diamanti AP; D'Amelio R; Signore A
    BioDrugs; 2013 Aug; 27(4):329-45. PubMed ID: 23558378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics in patients with skin diseases.
    Veilleux MS; Shear NH
    J Allergy Clin Immunol; 2017 May; 139(5):1423-1430. PubMed ID: 28477721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis: Unraveling the conundrum.
    Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
    J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
    Gan EY; Chong WS; Tey HL
    BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis in pregnancy: a review (II).
    Ruiz V; Manubens E; Puig L
    Actas Dermosifiliogr; 2014 Nov; 105(9):813-21. PubMed ID: 24314892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of biologic agents in pediatric psoriasis.
    Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
    J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The British Society for Rheumatology Biologics Register: 6 years on.
    Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
    Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous Manifestations of Reactions to Biologics.
    Otani IM; Levin AS; Banerji A
    Curr Allergy Asthma Rep; 2018 Feb; 18(2):12. PubMed ID: 29464437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biologics].
    Kalden JR
    Z Rheumatol; 2016 Aug; 75(6):604-10. PubMed ID: 27365024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biologics and cardiovascular risk].
    Tarner IH; Müller-Ladner U; Hamm C
    Z Rheumatol; 2010 Oct; 69(8):702-6, 708-11. PubMed ID: 20862482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics in dermatology: adverse effects.
    Sehgal VN; Pandhi D; Khurana A
    Int J Dermatol; 2015 Dec; 54(12):1442-60. PubMed ID: 26147909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
    Ruderman EM
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic Adverse Effects of Biologics for the Treatment of Atopy.
    Aranez V; Ambrus J
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):220-230. PubMed ID: 31301006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of New Biologics Is Important.
    Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):s113-s114. PubMed ID: 28809999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.